Skip to main content
Menu
US

AlphaPlate 384-well, light gray, untreated, case of 50

384-well light gray microplates specifically designed for AlphaLISA and AlphaScreen assays.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Surface Treatment Untreated
Color Gray
Detection Modality Alpha
Luminescence
Lids Included? No
Material Polystyrene
Sterility Non-Sterile
Plate Format 384 wells
Well Shape Flat-bottom
Well Volume 105 µL
Working Volume 24 - 90 µL

384-well light gray microplates specifically designed for AlphaLISA and AlphaScreen assays.

For research use only. Not for use in diagnostic procedures.

Product Variants
Unit Size: Case of 50
Part #:
6005350
List Price
USD 342.87
Unit Size: Case of 200
Part #:
6005359
List Price
USD 1,162.00

Overview

Packaging Notes:
  • Cases of 50 are packaged as 2 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.
  • Cases of 200 are packaged as 8 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.

Additional product information

Well plate dimensions

Well format: 384-well

Description Specification
Number of rows 16
Number of columns 24
Well volume 105 µL
Recommended working volume 24 µL- 90 µL
Height (mm) 14.35
Length (mm) 127.76
Width (mm) 85.48
Well diameter (mm) 3.65
Well depth (mm) 10.4
A1 to top offset (mm) 9.0
A1 to side offset (mm) 12.10
Well-to-well spacing (mm) 4.50
Volume 105 μL

 

 

Specifications

Color
Gray
Plate Format
384 wells
Volume
105.0 µL
Well Shape
Flat-bottom
Well Volume
105 µL
Working Volume
24 - 90 µL
Application
Research
Automation Compatible
Yes
Brand
AlphaPlate
Detection Modality
Alpha
Luminescence
Format
Microplates
Lids Included?
No
Material
Polystyrene
Shipping Conditions
Shipped Ambient
Sterility
Non-Sterile
Surface Treatment
Untreated
Unit Size
Case of 50

Resources

Are you looking for resources, click on the resource type to explore further.

7-12 of 13 Resources
Application Note Icon
Application Note
Detection of MAPK activation to evaluate the efficacy and potency of KRAS/SOS1 inhibitors by AlphaLISA and HTRF technologies

Evaluation of the therapeutic profile of anti-oncogene compounds in various cell lines with AlphaLISA™ and HTRF™

KRAS is a proto...

Application Note Icon
Application Note
Measuring strong to weak binding interactions with AlphaLISA

Biomolecular interactions are crucial for biological processes like transcription, translation, and cell signaling. These...

Application Note Icon
Application Note
No-Wash IP1 assays are a powerful readout to characterize compounds modulating the FGFR signaling pathway in cancer drug research

The success of cancer therapies can be influenced by the interaction between multiple signaling pathways. Dysregulated FGFR...

Application Note Icon
Application Note
Simultaneous detection of drug efficacy and toxicity by combining HTRF, AlphaLISA, or AlphaLISA SureFire Ultra with ATPlite

This application note demonstrates how compound’s mechanism of action and potential cytotoxic effects can be deciphered thanks to...

Application Note Icon
Application Note
Simultaneous measurement of chemokine/cytokine release and antibody-dependent cellular cytotoxicity upon binding with rituximab

Antibody-dependent cellular cytotoxicity (ADCC) is a cell-mediated immune response where an effector cell destroys an antibody...

Application Note Icon
Application Note
Tracking inflammasome activity via measuring IL-1β levels with AlphaLISA and HTRF

It has been suggested that inflammation promotes malignancy via proinflammatory cytokines, such as IL-1ß, which enhance immune...

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Technical data sheet
+ Show more
Scroll Icon